Myocardial bridging (MB) is defined as a segment of myocardial tissue overlaying a portion of a coronary artery and constitutes one of the congenital variants of coronary anatomy. In certain cases, the MB may induce systolic compression of the underlying coronary artery segment. Traditionally, the presence of an MB has been regarded as a benign anatomical variant. Nevertheless, according to current literature, patients with MBs in the absence of obstructive coronary artery disease demonstrate an elevated risk of adverse cardiovascular events. At present, there are no formal clinical guidelines or expert consensus statements that delineate the diagnostic and therapeutic management strategies for patients presenting with symptomatic MBs. In this study, we aimed to address several critical questions, namely: how to establish an association between the presence of an MB and clinical manifestations of coronary insufficiency, which therapeutic approach should be tailored to individual patients with MB, and, under what circumstances endovascular revascularization should be considered and, importantly, how to perform the stenting procedure both effectively and safely?